Dr. Ryan Morin (Centre for Lymphoid Cancer) is the co-recipient of the Canadian Cancer Society (CCS) Bernard and Francine Dorval Prize.
Dr. Morin is a national and international leader in his field of studying how changes to our genes lead to cancer. He has conducted cutting-edge research that has directly helped doctors understand, diagnose and better treat lymphomas.
Despite decades of advancement in treatment, cancer spreading to multiple parts of the body remains one of the biggest challenges facing patients and their health care teams.
This is particularly true for osteosarcoma, the most common bone cancer in children and teenagers. While survival rates are approximately 70 per cent for people with localized disease, there is a high risk of metastatic spread to the lungs, after which the odds of survival fall dramatically to 20 per cent or less.
In a new study, a team led by Dr. Dean Regier, Senior Scientist in Cancer Control at BC Cancer and co-chair of the MOHCCN Health Technology Assessment Working Group, conducted focus groups with individuals with lived and living experience with cancer to understand their values, expectations, and concerns for enhanced data sharing.
She introduced additional recycling bins, illustrative posters and education at BC Cancer – Abbotsford and Paulina Batke, registered nurse, saw an 83 per cent reduction in the number of recyclable items tossed in the garbage over four weeks.
A multidisciplinary team comprised of clinical experts, operations leaders and ambulatory clinic managers from BC Cancer have published a paper in the BC Medical Journal titled, “Eliminating the routine use of examination table paper in outpatient oncology clinics.”
Dr. Poul Sorensen (Molecular Oncology), with co-investigators Dr. Kevin Hay (Terry Fox Laboratory) and Dr. Wei Li (University of Pittsburgh), received a Project Grant from the Canadian Institutes of Health Research (CIHR) for their project titled, “Targeting metabolic vulnerabilities in childhood cancers using immunotherapy.”
BC Cancer Foundation is the fundraising partner of BC Cancer, which includes BC Cancer Research. Together with our donors, we are changing cancer outcomes for British Columbians by funding innovative research and personalized treatment and care.